Sergliflozin etabonate

Sergliflozin etabonate, a SGLT-2 inhibitor, is used potentially for the treatment of type 2 diabetes and obesity.

408504-26-7

≥ 2 years

>98% (HPLC)

448.468

C23H28O9

Research use only, not for human use.

Protoporphyrinogen oxidase

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MBS2604346-01 48 Well

Ask

MBS2604346-02 96 Well

Ask

MBS2604346-03 5x 96 Well

Ask

MBS2604346-04 10x 96 Well

Ask

RR202293 10 µg

Ask

MBS2541208-01 0.06 mL

Ask